LEGN
Legend Biotech Corp
NASDAQ: LEGN · HEALTHCARE · BIOTECHNOLOGY
$22.77
-3.35% today
Updated 2026-04-29
Market cap
$4.21B
P/E ratio
—
P/S ratio
4.09x
EPS (TTM)
$-1.62
Dividend yield
—
52W range
$16 – $45
Volume
1.9M
Legend Biotech Corp (LEGN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-148.0%
Last 4 quarters
Revenue YoY growth
+64.9%
Most recent quarter
EPS YoY growth
-214.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.3%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-3.7%
2026-03-18
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-18 | $-0.16 | -1802.1% | $18.55 | $17.87 | -3.7% |
| 2025-11-12 | $-0.11 | -146.1% | $32.03 | $31.01 | -3.2% |
| 2025-08-11 | $-0.34 | -183.3% | $37.00 | $36.99 | -0.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.01 | $-0.16 | -1802.1% | $307.64M | +64.9% |
| 2025-09-30 | $-0.04 | $-0.11 | -146.1% | $272.33M | +70.0% |
| 2025-06-30 | $-0.12 | $-0.34 | -183.3% | $255.06M | +36.7% |
| 2025-03-31 | $-0.25 | $-0.54 | -112.6% | $195.05M | +107.5% |
| 2024-12-31 | $-0.38 | $0.14 | +137.2% | $186.52M | +134.7% |
| 2024-09-30 | $-0.42 | $-0.68 | -62.8% | $160.21M | +66.9% |
| 2024-06-30 | $-0.38 | $-0.10 | +73.7% | $186.52M | +154.4% |
| 2024-03-31 | $-0.34 | $-0.16 | +52.9% | $93.99M | — |
| 2023-12-31 | $-0.83 | $-0.80 | +3.6% | $79.46M | — |
| 2023-09-30 | $-0.68 | $-0.34 | +50.0% | $96.01M | — |
| 2023-06-30 | $-0.60 | $-1.14 | -90.0% | $73.33M | — |
Frequently asked questions
Has Legend Biotech Corp beaten earnings estimates?
Legend Biotech Corp has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -148.0% over the last 2 quarters.
How does LEGN stock react to earnings?
LEGN stock has moved an average of -2.3% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.
What is Legend Biotech Corp's revenue growth rate?
Legend Biotech Corp reported year-over-year revenue growth of +64.9% in its most recent quarter, with EPS growing -214.3% year-over-year.